Plain-English translation of NCT07625943 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a faster radiation therapy schedule can work just as well as the standard longer schedule for treating cervical cancer. Currently, women receive external beam radiation five days a week for five weeks, along with chemotherapy and additional internal radiation (brachytherapy). The study will compare this standard approach to a newer, shorter schedule that delivers radiation over about three weeks instead.
Many women with cervical cancer struggle to complete the standard five-week treatment because of the time commitment, travel costs, and difficulty taking time off work. When treatment gets delayed or interrupted, cancer can grow faster. Doctors want to know whether shortening the external radiation part of treatment—while keeping the total radiation dose and chemotherapy the same—could help women complete their care more easily without sacrificing results.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the standard five-week radiation schedule or the newer three-week schedule. Both groups will also receive weekly chemotherapy (cisplatin) and internal radiation (brachytherapy) treatments. You will have regular visits for treatment planning, scans, blood tests, and follow-up appointments to monitor your progress and any side effects. The trial will track how well the treatment works and how it affects your quality of life over time.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India